|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Home : Leadership : Jonathan Ma Jonathan Ma, PhDPOSITIONS HELD July 2001 – Present
Associate Director/Biometrics Primary statistician supporting clinical trials on the lipid lowering agent Lipitor in the Cardiovascular/Metabolic division. Handling all statistical issues for the Phase 3/4 studies and providing statistical support to relevant clinical teams and marketing teams, including study design, SAP writing, study conduct/monitoring, various committee and investigator/coordinator meetings, TLF generation, study report writing, response to regulatory requests, etc. Overseeing CROs on all statistical deliverables. Taking lead of the biometrics team to support other medical and marketing initiatives, such as marketing promotion materials, publications, annual safety report, etc.
March 2000 – July
2001 Manager, Biostatistics Managed biostatistical work and played a key role in providing biostatistical support to projects as follows: Acted as a lead biostatistician on project teams; overviewed the project progress; organized responses to issues and requests raised by sponsors or regulatory agencies in a timely and effective fashion; met with sponsors as requested during protocol development to ensure adequacy of proposed study designs with respect to statistical feasibility; provided biostatistical consultation from the regulatory perspectives; wrote statistical sections of study protocols and formal statistical analysis plans to be carried out in the analysis of clinical studies; interacted with other Ingenix International departments to ensure a high level of client satisfaction. October 1995 - March 2000
Mathematical Statistician Provided statistical evaluation for investigational new drug applications (INDs) and new drug applications (NDAs) submitted by drug companies. Reviewed therapeutic areas included anesthetics, addiction, metabolic and endocrine, antiviral and pre-clinical carcinogenicity studies. Evaluated the techniques and interpretation of the statistical analyses performed by drug companies and identified potential problems and biases. Performed appropriate alternative analyses to verify sponsor’s conclusions. Worked closely with other members of the review team, including Medical Officer, pharmacologist, pharmacokinetist, etc., and provided consultation on all statistical issues risen from their review processes. Periodically reported review progress and major statistical issues identified during the review process to division directors and other members of the review team on internal status review meetings. Attended sponsor meetings and teleconferences and provided guidance and consultation on issues related to study design and statistical analysis.
Wrote statistical evaluations and/or reports on 12 NDAs, dozens of INDs and other projects.
September 1991 - May 1995 Yale
University Research Support Specialist - Worked in the Biostatistics Consulting Unit as a consultant and analyzed data from various research projects using both parametric and non-parametric statistical techniques. Research Assistant – Applied statistical modeling techniques to link between the incidence and mortality rates of lung cancer from the Connecticut Tumor Registry data. Teaching Assistant - Directed group discussions for basic statistical courses.
June 1992 - August 1992
Summer Intern Analyzed data from clinical trials comparing drugs for treating HIV infection: AZT, DDI and D4T. Finished a complete SAS package for a two-sample asymptotically distribution-free test for incomplete multivariate distributions. May 1990 - July 1991
Research Assistant
Developed
nonparametric estimators for the survival functions of stochastically
ordered random variables. Copyright © 2004 Kinexum LLC | terms of use | privacy |
|
||||||||||||||||||||